|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3 Pt 1
|
|
pubmed:dateCreated |
2006-2-9
|
|
pubmed:abstractText |
Breast cancer is a heterogeneous disease, and markers for disease subtypes and therapy response remain poorly defined. For that reason, we employed a prospective neoadjuvant study in locally advanced breast cancer to identify molecular signatures of gene expression correlating with known prognostic clinical phenotypes, such as inflammatory breast cancer or the presence of hypoxia. In addition, we defined molecular signatures that correlate with response to neoadjuvant chemotherapy.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:BildAndreaA,
pubmed-author:BlackwellKimberlyK,
pubmed-author:DewhirstMark WMW,
pubmed-author:DressmanHolly KHK,
pubmed-author:HansChristopherC,
pubmed-author:JonesEllen LEL,
pubmed-author:LiotchevaVlayka BVB,
pubmed-author:MarcomP KellyPK,
pubmed-author:MarksJeffreyJ,
pubmed-author:NevinsJoseph RJR,
pubmed-author:OlsonJohn AJA,
pubmed-author:RosenEricE,
pubmed-author:VujaskovicZeljkoZ,
pubmed-author:WestMikeM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
819-26
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16467094-Breast Neoplasms,
pubmed-meshheading:16467094-Female,
pubmed-meshheading:16467094-Follow-Up Studies,
pubmed-meshheading:16467094-Gene Expression Profiling,
pubmed-meshheading:16467094-Humans,
pubmed-meshheading:16467094-Neoadjuvant Therapy,
pubmed-meshheading:16467094-Neoplasm Staging,
pubmed-meshheading:16467094-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:16467094-Phenotype,
pubmed-meshheading:16467094-Prognosis,
pubmed-meshheading:16467094-Retrospective Studies,
pubmed-meshheading:16467094-Survival Rate
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy.
|
|
pubmed:affiliation |
Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Duke University, Durham, North Carolina 27710, USA. dress002@mc.duke.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
